Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids

Australas J Dermatol. 2018 Aug;59(3):e168-e174. doi: 10.1111/ajd.12762. Epub 2018 Feb 7.

Abstract

Derivatives of hydrocortisone, such as mometasone furoate, a (2') furoate-17 ester with chlorine substitutions at positions 9 and 21, have been designed to improve efficacy and reduce the incidence of adverse effects. An extensive literature search of MEDLINE, Embase and other databases was conducted to review the safety and efficacy of various formulations of topical mometasone furoate. Mometasone furoate exhibits high potency with greater anti-inflammatory activity and a longer duration of action than betamethasone. In clinical trials, mometasone furoate shows comparable or significantly better efficacy, depending on the comparator, in all indications studied in both adults and children. It is well tolerated with only transient, mild to moderate local adverse effects. It is characterised by low systemic availability due to its high lipophilicity, low percutaneous absorption and rapid hepatic biotransformation, and consequently has no significant effect on the hypothalamic-pituitary-adrenal axis. The molecular biotransformation of mometasone furoate in the skin results in a lower affinity with dermal cells than epidermal cells, which contributes to its low atrophogenicity. Sensitisation to mometasone furoate is low. Overall, mometasone furoate is a highly efficacious potent corticosteroid with a low risk of both local and systemic adverse effects.

Keywords: corticosteroid; eczema; mometasone furoate; psoriasis; seborrhoeic dermatitis.

Publication types

  • Review

MeSH terms

  • Administration, Topical
  • Betamethasone / therapeutic use
  • Dermatologic Agents / adverse effects
  • Dermatologic Agents / pharmacokinetics
  • Dermatologic Agents / therapeutic use*
  • Humans
  • Mometasone Furoate / adverse effects
  • Mometasone Furoate / pharmacokinetics
  • Mometasone Furoate / therapeutic use*

Substances

  • Dermatologic Agents
  • Mometasone Furoate
  • Betamethasone